Liver Failure in patients treated with chemotherapy for colorectal liver metastases: Role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysis

European Journal of Surgical Oncology

Volumn 40, Issue 11, 2014, Pages 1550-1556

  Ratti, F ^a   Cipriani, F ^a   Catena, M ^a   Paganelli, M ^a   Aldrighetti, L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Liver surgery; Metastases; Postoperative Liver Failure; Sinusoidal obstruction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; BILIRUBIN; CREATININE; FLUOROURACIL; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; OXALIPLATIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PLATINUM COMPLEX;

ACCURACY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; ASSESSMENT OF HUMANS; BILE DUCT FISTULA; BILIRUBIN BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CAUSE OF DEATH; CHOLANGITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COLON CANCER; COLORECTAL LIVER METASTASIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FIBROSIS 4 SCORE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER RESECTION; LIVER SURGERY; MALE; MORTALITY; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SEPTIC SHOCK; THROMBOCYTE COUNT; URINARY TRACT INFECTION; WOUND INFECTION; ADJUVANT THERAPY; ADVERSE EFFECTS; AGED; BLOOD; CHRONIC DISEASE; COLORECTAL TUMOR; DRUG-INDUCED LIVER INJURY; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SECONDARY; STATISTICAL ANALYSIS;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; CHRONIC DISEASE; COLORECTAL NEOPLASMS; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATECTOMY; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84922480327     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.06.011     Document Type: Article

References (25)

1. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009 Aug 1;27(22):3677-83.
2. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008 Mar 22;371(9617):1007-16.
3. Blazer 3rd DG, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 2008 Nov 20;26(33):5344-51.
4. Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008 Jan; 247(1):118-24.
5. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006 Jan; 243(1):1-7.
6. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006 May 1;24(13):2065-72.
7. Pulitanó C, Aldrighetti L, Arru M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006 Nov; 244(5):833-5.
8. Rubbia-Brandt L, Audard V, Sartoretti P, et al. severe hepatic sinusoidal obstruction associated with oxaliplatin-bades chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004 Mar; 15(3):460-6.
9. Hammond JS, Guha IN, Backingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. Br J Surg 2011 Sep; 98(9):1188-200.
10. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chomotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006 Nov 1;24(31):4983-90.
11. Wai CT, Greenson JK, Fontana RJ, et al. A simple and noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 Aug; 38(2):518-26.
12. Soubrane O, Brouquet A, Zalinski S, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with posthepatectomy outcome. Ann Surg 2010 Mar; 251(3):454-60.
13. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999 Feb; 229(2):210-5.
14. Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 2007 Apr; 204(4):580-7.
15. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713-24.
16. Aldrighetti L, Pulitanó C, Arru M, Catena M, Finazzi R, Ferla G. "Technological" approach versus clamp crushing technique for hepatic parenchymal transection: a comparative study. J Gastrointest Surg 2006 Jul-Aug; 10(7):974-9.
17. Terminology Committee of the International Hepato-Pancreato-Biliary Association. The IHPBA Brisbane 2000 terminology of liver anatomy and resections. HPB Surg 2000;2:333-9.
18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004 Aug; 240(2):205-13.
19. Nordlinger B, Van Cutsem E, Gruenberg T, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009 Jun; 20(6):985-92.
20. Van Vledder MG, de Jong MC, Pawlik TM, Schulik RD, Diaz LA, Choti MA. Disappearing colorectal liver metastases after chemotherapy: should web - concerned? J Gastrointest Surg 2010 Nov; 14(11):1691-700.
21. Auer RC, White RR, Kemeny NE, et al. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer 2010 Mar. 15; 116 (6).
22. Ribero D, Wang H, Donadon M, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007 Dec 15;110(12):2761-7.
23. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006 Apr 7;312(5770):104-7.
24. McHutchison JG, Blatt LM, de Medina M, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000 Aug; 15(8):945-51.
25. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 Dec; 38(6):1449-57.